Agencies
... Read More
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy.
Written By: Agencies | Published : December 12, 2014 1:22 PM IST
Geneva, Dec 11: A clinical trial of an Ebola vaccine has been suspended after four patients complained of joint pains in their limbs, the University of Geneva hospital said Thursday. 'They are all fine and being monitored regularly by the medical team leading the study,' The Guardian quoted the hospital as saying in a statement.
The trials of the vaccine, developed by pharmaceutical firms Merck and NewLink, will now begin Jan 5. The decision to suspend the trials comes as health officials in Sierra Leone discovered scores of bodies in a remote diamond-mining area, raising fears of a spike in the number of unreported deaths. The World Health Organisation said it uncovered a 'grim scene' in Sierra Leone's Kono district. (Read: Ebola vaccine works on monkeys, will it work on humans?)
Sierra Leone has now overtaken Liberia as the country with the highest number of Ebola cases in west Africa, with 7,897 cases since the beginning of the outbreak. The Ebola epidemic has killed more than 6,000 people in west Africa. (Read: Why pharma companies did not develop Ebola vaccine earlier)
Source: IANS
Photo source: Getty images
For more articles on Ebola virus, visit our Ebola virus section. For daily free health tips, sign up for our newsletter.
